Vimarsana
Biggest News Aggregation in the World

Page 3 - Target Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Segment Today - Breaking & Trending Today

Aarti Drugs' unit gets approval under pharma PLI scheme - Vimarsana News

Aarti Drugs' unit gets approval under pharma PLI scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs has received an approval accorded under Production Linked Incentive (PLI) scheme for pharmaceutical sector. Government of India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in Fermentation based - at least 90% and Two in the Chemical Syn...

Moderate gains seen at open, but crude, FPI flow to anchor direction - Vimarsana News

Moderate gains seen at open, but crude, FPI flow to anchor direction

Moderate gains seen at open, but crude, FPI flow to anchor direction March 08, 2021 × Asian markets in early trade on Monday are up 0.5-1.5%; US markets on Friday closed up 1.55-2%; analysts fear the market may see volatility The Indian stock markets, after falling a couple of days, are expected to open on a positive note on Monday, thanks to global markets. The SGX Nifty, ruling at 15,080, points to a 130-point gain for Nifty futures, which on Friday closed at 14,953 on the NSE. Asian markets in early trade on Monday are up in the range of between 0.5 and 1.5 per cent. Australian indices ar...

Aarti Drugs' unit benefits from Govt.'s PLI Scheme - Vimarsana News

Aarti Drugs' unit benefits from Govt.'s PLI Scheme

Aarti Speciality Chemicals, a wholly-owned subsidiary of Aarti Drugs (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India's recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to promote domestic manufacturing by incentivising pharmaceutical manufacturers to set-up greenfield projects in India with a minimum domestic value addition in four different target segments (Two in ...

Sensex closes almost flat, Nifty fails to reclaim 15,000 - Vimarsana News

Sensex closes almost flat, Nifty fails to reclaim 15,000

Read more about Sensex closes almost flat, Nifty fails to reclaim 15,000 on Business Standard. Domestic equity benchmarks ended with small gains on Monday. Banks, IT, metals and pharma stocks advanced while autos, financials and FMCG shares declined. The Nifty closed near the 15,000 mark.

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector - Vimarsana News

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector

Aarti Speciality Chemicals Limited receives an approval accorded under PLI Scheme for Pharmaceutical Sector Posted On: 2021-03-06 04:25:29 (Time Zone: Arizona, USA) Aarti Speciality Chemicals Limited (ASCL), a wholly-owned subsidiary of Aarti Drugs Limited (Aarti Drugs), stands out to be one of the beneficiaries of the Government of India's recently approved Production Linked Incentive (PLI) for the Pharmaceutical Sector. Government of India's Department of Pharmaceuticals under the Ministry of Chemicals and Fertilizers recently launched a Production Linked Incentive (PLI) Scheme to prom...